These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia. Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL; Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819 [TBL] [Abstract][Full Text] [Related]
10. [What is the value of the combination atovaquone-proguanil for the clinician?]. Delmont J Med Trop (Mars); 2002; 62(3):232-6. PubMed ID: 12244917 [TBL] [Abstract][Full Text] [Related]
11. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity. Lacy MD; Maguire JD; Barcus MJ; Ling J; Bangs MJ; Gramzinski R; Basri H; Sismadi P; Miller GB; Chulay JD; Fryauff DJ; Hoffman SL; Baird JK Clin Infect Dis; 2002 Nov; 35(9):e92-5. PubMed ID: 12384852 [TBL] [Abstract][Full Text] [Related]
12. Atovaquone plus chloroguanide versus mefloquine for malaria prophylaxis: a focus on neuropsychiatric adverse events. van Riemsdijk MM; Sturkenboom MC; Ditters JM; Ligthelm RJ; Overbosch D; Stricker BH Clin Pharmacol Ther; 2002 Sep; 72(3):294-301. PubMed ID: 12235450 [TBL] [Abstract][Full Text] [Related]
13. [symbol: see text] Atovaquone + proguanil for malaria prophylaxis. Drug Ther Bull; 2001 Oct; 39(10):73-5. PubMed ID: 11706518 [TBL] [Abstract][Full Text] [Related]
14. Atovaquone and proguanil versus amodiaquine for the treatment of Plasmodium falciparum malaria in African infants and young children. Borrmann S; Faucher JF; Bagaphou T; Missinou MA; Binder RK; Pabisch S; Rezbach P; Matsiegui PB; Lell B; Miller G; Kremsner PG Clin Infect Dis; 2003 Dec; 37(11):1441-7. PubMed ID: 14614665 [TBL] [Abstract][Full Text] [Related]
15. Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil. van Vugt M; Leonardi E; Phaipun L; Slight T; Thway KL; McGready R; Brockman A; Villegas L; Looareesuwan S; White NJ; Nosten F Clin Infect Dis; 2002 Dec; 35(12):1498-504. PubMed ID: 12471569 [TBL] [Abstract][Full Text] [Related]
16. [Clinical studies using the combination atovaquone-proguanil as malaria prophylaxis in non-immune adult and child travelers]. Camus D; Dutoit E; Masson V; Inglebert P; Delhaes L Med Trop (Mars); 2002; 62(3):225-8. PubMed ID: 12244915 [TBL] [Abstract][Full Text] [Related]
17. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Malarone International Study Team. Høgh B; Clarke PD; Camus D; Nothdurft HD; Overbosch D; Günther M; Joubert I; Kain KC; Shaw D; Roskell NS; Chulay JD; Lancet; 2000 Dec; 356(9245):1888-94. PubMed ID: 11130385 [TBL] [Abstract][Full Text] [Related]
18. [Pharmaceutical care for international voyagers: prophylaxis including chloroquine plus proguanil]. Hernández Tintorer JL; Lorduy Osés L Farm Hosp; 2004; 28(2):137-40. PubMed ID: 15101806 [TBL] [Abstract][Full Text] [Related]
19. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria. McKeage K; Scott L Drugs; 2003; 63(6):597-623. PubMed ID: 12656656 [TBL] [Abstract][Full Text] [Related]
20. The safety and tolerance of atovaquone/proguanil for the long-term prophylaxis of plasmodium falciparum malaria in non-immune travelers and expatriates [corrected]. van Genderen PJ; Koene HR; Spong K; Overbosch D J Travel Med; 2007; 14(2):92-5. PubMed ID: 17367478 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]